000 | 01400 a2200397 4500 | ||
---|---|---|---|
005 | 20250517091112.0 | ||
264 | 0 | _c20171023 | |
008 | 201710s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/bph.13495 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSingh, Neetu | |
245 | 0 | 0 |
_aInhibition of fatty acid synthase is protective in pulmonary hypertension. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _c06 2016 |
||
300 |
_a2030-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a4-Butyrolactone _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aFatty Acid Synthases _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Pulmonary _xenzymology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aManhas, Amit | |
700 | 1 | _aKaur, Gurpreet | |
700 | 1 | _aJagavelu, Kumaravelu | |
700 | 1 | _aHanif, Kashif | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 173 _gno. 12 _gp. 2030-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13495 _zAvailable from publisher's website |
999 |
_c25908842 _d25908842 |